ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
版权信息 · Copyright

     加入编委 / 副主编 / 同行评议专家
ISSN 3105-6741(Print)
ISSN 3105-675X(Online)

CODEN:LYYAA3
国际标准连续出版物标识符·全球唯一标识符
分配机构:美国化学文摘社(CAS)
DOI前缀:
https://doi.org/10.66106/lyyaa3
国图集团 CIBTC
进口备案刊号:G015Z125

索引 检索 存档(Global Indexing)
本刊入选以下全球权威数据库,致力于研究成果的全球化无障碍传播。

CNKI(中国知网,申请中)
CNKI Open(中国知网·开放平台,申请中)
Wanfang Data(万方数据,中国,更新中)
CQVIP(维普期刊网,中国)
CQVIP(中文期刊服务平台,中国)
RCCSE(中国学术期刊目录,武汉大学)
CJWK(长江文库,中国)
BOOKAN(博看,中国)
591adb(中邮阅读·万章期刊,中国)
Baidu Scholar(百度学术,中国)
Baidu Baike(百度百科,中国)
ICI(哥白尼期刊数据库,波兰)
EuroPub(欧洲学术出版数据库,英国)
MDPI scilit(科学与学术数据库,瑞士)
Crossref(交叉引用,美国)
Semantic Scholar(语义学术,美国)
OpenAlex(全球开源学术平台,加拿大)
ACADEMIA.EDU(学术界,美国)
OUCI(开放乌克兰科学,乌克兰)
WorldCat(世界编目数据库,美国)
Scite(智能引文分析数据库,美国)
The Lens(透镜学术,澳大利亚)
OpenAIRE(开放学术发现门户,欧洲)
Google Scholar(谷歌学术,美国)
DOI(数字对象唯一标识符,英国)
Portico(数字存储库,美国)
J-Gate(开放获取期刊门户,印度)
ResearchGate(研究之门,德国)
Research Commons(科睿唯安,美国)
Socolar(开放获取资源检索,中国,更新中)
Sci Online(科学在线,中国澳门)
OALib(开放存取资源图书馆,美国)
EZB(电子期刊图书馆,德国,申请中)
Road(开放科学学术资源,法国)
ISI(国际科学索引平台,阿联酋迪拜)
ASCI(亚洲科学引文索引,美国)
ESJI(欧亚科学期刊索引,哈萨克斯坦)
ResearchBib(研究者索引,日本)
SPI-Hub™(范德比尔特大学,美国)
SJIF(科学期刊影响因子,印度)
RJIF(研究期刊影响因子)
COSMOS(期刊评价指标,印度)
LivRe!(开放期刊门户,巴西)
KIND CONGRESS(阿塞拜疆)
Journament(质量评估与索引)
IP Indexing(ip索引)
Magzter(跨平台数字期刊,美国)
SlideShare(知识共享平台,美国)
SCRIBD(在线图书馆,美国)
Yahoo! Search(雅虎,美国)
Microsoft Bing(微软学术,美国)
LibKey(学术文献快捷获取工具)
R Discovery(研究者发现平台,印度)
Enterscholar(恩特学术)

规划申请
Scopus 爱思唯尔·斯高帕斯(荷兰)

SinoMed 中国生物医学文献服务系统
DOAJ 开放获取期刊目录(瑞典)
PubMed 医学文摘数据库(美国)
PubMed Central 医学全文数据(美国)
EMBASE 爱思唯尔·医学文摘(荷兰)
EBSCO 学术文献数据库(美国)
OAJ 全球OA期刊索引(中国)

CABI 国际农业与生物科学中心(英国)
ProQuest 科睿唯安(美国)
Research4Life 世界卫生组织数据库


武汉办事处
主任 库盛娟
电话 +86 027-8860 7188
邮箱 gjqk@qikan999.com
微信 qikan7188
地址 武汉市武昌东湖路181号
邮编 430077
Editing and Publishing
Macau Sino-Foreign Medical Publishing Limited(MSFMP)
Address
Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
https://lcyyyj.scionline2025.com

  往期阅览 · All Issues-> 2025年 · 2025  
临床用药研究2025年第1卷第2期第80-87页,pISSN 3105-6741、eISSN 3105-675X 发布者:Quest Press 发布日期:2026/1/11
Open Access 浏览246

 

基于网络药理学及分子对接研究小儿荆杏止咳颗粒治疗急性支气管炎的作用机制


李世珍,和旭丽,申翠平

1.吕梁市人民医院,山西吕梁,033099 2.太原市妇幼保健院,山西太原,030012 3.长治市人民医院,山西长治,046000

摘要:目的:通过网络药理学和计算机分子对接技术研究小儿荆杏止咳颗粒治疗急性支气管炎的作用机制。方法:使用TCMSP平台及文献数据搜索建立小儿荆杏止咳颗粒物质基础数据库,以ADMET3.0和TCMSP等平台进行成药性评价筛选,利用PDB及Uniprot数据库对靶点蛋白基因名称标准化;利用Genecards数据库和OMIM数据库对急性支气管炎的相关靶点进行收集和筛选;通过Venny2.1.0软件获取小儿荆杏止咳颗粒治疗急性支气管炎的潜在靶点后导入STRING数据库构建蛋白相互作用网络;采用Cytoscape3.10.3软件构建药物-成分-靶点网络;接着用David和Metascape数据库进行GO/KEGG通路富集。最后通过Autodockvina软件将小儿荆杏止咳颗粒活性成分与急性支气管炎核心靶点进行分子对接研究。结果:获得小儿荆杏止咳颗粒靶点1004个,急性支气管炎靶点1150个,小儿荆杏止咳颗粒作用于急性支气管炎靶点177个,进一步发现核心靶点与炎症通路密切相关。结论:小儿荆杏止咳颗粒可能通过鼠尾草素、5,7,2',6'-四羟基黄酮、刺槐素、乌拉尔宁B、粘毛黄芩素Ⅱ等活性成分群多靶点多重作用机制共同作用,研究发现SRC、NFKB1、MTOR、CASP3和AKT1等为小儿荆杏止咳颗粒作用的核心靶点,通过调节白细胞介素信号传导通路、细胞迁移的正向调控、胃泌素信号传导、急性病毒性心肌炎等通路,起到抗炎、抗氧化作用,对急性支气管炎起到治疗作用,为小儿荆杏止咳颗粒临床治疗提供实验基础和理论依据。

关健词:小儿荆杏止咳颗粒;急性支气管炎;成药性评价;作用机制;网络药理学;分子对接
Study on the Mechanism of Action of Xiao'er Jingxing Zhike Granules in Treating Acute Bronchitis Based on Network Pharmacology and Molecular Docking

Shizhen Li1,Xuli He,Cuiping Shen

1.The People’s Hospital of Lvliang,Lvliang,Shanxi 033099,China 2.Taiyuan Maternity and Child Health Care Hospital,Taiyan,Shanxi 030012,China 3.Changzhi People's Hospital,Changzhi,Shanxi 046000,China

Abstract:Objective:To investigate the mechanism of action of Xiao'er Jingxing Zhike Granules in treating acute bronchitis using network pharmacology and molecular docking techniques.Methods:A material basis database for Xiao'er Jingxing Zhike Granules was established using the TCMSP platform and literature data. Drug-likeness evaluation and screening were conducted using platforms such as ADMET 3.0 and TCMSP. The target protein gene names were standardized using the PDB and Uniprot databases. Acute bronchitis-related targets were collected and screened using the Genecards and OMIM databases. Potential targets for Xiao'er Jingxing Zhike Granules in treating acute bronchitis were obtained using Venny 2.1.0 software and then imported into the STRING database to construct a protein-protein interaction (PPI) network. A drug-component-target network was constructed using Cytoscape 3.10.3 software. GO/KEGG pathway enrichment analysis was performed using the DAVID and Metascape databases. Finally,molecular docking studies were conducted using Autodock Vina software to investigate the interaction between the active components of Xiao'er Jingxing Zhike Granules and the core targets of acute bronchitis.Results:A total of 1004 targets for Xiao'er Jingxing Zhike Granules and 1150 targets for acute bronchitis were identified. Among these,177 targets were found to be common between Xiao'er Jingxing Zhike Granules and acute bronchitis. Further analysis revealed that the core targets are closely related to inflammatory pathways.Conclusion:Xiao'er Jingxing Zhike Granules may act on multiple targets and pathways through active components such as Salvigenin,5,7,2',6'-Tetrahydroxyflavone,Robinin,Uralenin B,and Viscidulin II. These components target core proteins such as SRC,NFKB1,MTOR,CASP3,and AKT1,regulating pathways including interleukin signaling,positive regulation of cell migration,gastrin signaling,and acute viral myocarditis. This multi-target,multi-pathway approach exerts anti-inflammatory and antioxidant effects,providing a therapeutic effect on acute bronchitis. This study provides an experimental and theoretical basis for the clinical use of Xiao'er Jingxing Zhike Granules in treating acute bronchitis.


Keywords : Xiao'er Jingxing Zhike Granules;Acute Bronchitis;Drug-likeness Evaluation;Mechanism of Action;Network Pharmacology;Molecular Docking


参考文献
[1] 刘志美,张瑜,马闻园,等.小儿抗炎胶囊治疗小儿急性支气管炎(风热咳嗽证)[J].吉林中医药,2023,43(10):1166-1169.DOI:10.13463/ j.cnki.jlzyy. 2023.10.012.
[2] 徐贤达,陈晓婷,杨芬.加味麻杏石甘汤治疗对小儿急性支气管炎患儿中医证候积分和炎症因子水平的影响[J].现代医学与健康研究电子杂志,2024,8(23):99-101.
[3] 史卜文,吕健,谢雁鸣,等.肺力咳合剂联合常规西药治疗小儿支气管炎的有效性和安全性系统评价与 Meta 分析[J].中国中医药信息杂志,2023,30(01):67-74.DOI:10.19879/j.cnki.1005-5304.202107545.
[4] 马莹,苏林博,吴辉,等.精细化护理管理在小儿急性支气管炎中的应用[J].河南医学高等专科学校学报,2024,36(05):651-653.
[5] 曹丽洁,欧阳侯静,付铄淇.中西医结合护理模式在小儿急性支气管炎中的应用价值[J].西部中医药,2023,36(08):123-126.
[6] 黄静,陈安静,鲁云倩,等.自拟“消咳贴”治疗小儿急性咳嗽风寒化热证的临床观察[J].中国中西医结合儿科学,2022,14(06):542-545.
[7] 魏向阳,张星平,张学青,等.痰热壅肺型小儿咳嗽变异性哮喘及小儿急性支气管炎异病同治刍议[J].中国药物经济学,2023,18(04):114-117+121.
[8] 刘咏梅,冯会颖,殷美乐,等.小儿荆杏止咳颗粒联合利巴韦林治疗小儿急性上呼吸道感染的临床研究[J].现代药物与临床,2024,39(09):2328-2332.
[9] 吴志坚,陈秋萍,刘素云.小儿荆杏止咳颗粒联合孟鲁司特钠治疗支气管肺炎患儿效果观察[J].天津药学,2023,35(04):40-43.
[10] 张琪,常久,季巍巍,等.网络药理学在中医药领域的研究进展[J].中国中医药信息杂志,2024,31(11):186-190.DOI:10.19879/j.cnki.1005-5304.202207685.
[11] 杨思佳,王晓燕,陈清清,等.急性支气管炎患儿不良预后发生率及多因素回归预测模型分析[J].中国妇幼保健,2024,39(19):3786-3789.DOI: 10. 19829/ j.zgfybj.issn.1001-4411.2024.19.026.
[12] 颉雅苹,曾强,陶建平,等.67 例儿童感染后闭塞性细支气管炎的临床特征与随访研究[J].临床肺科杂志,2023,28(05):689-693.
[13] 尹晓炜.小儿荆杏止咳颗粒辅助治疗小儿急性支气管炎的临床分析[J].适用中西医结合临床,2021,21(21):40-41.DOI:10.13638/j.issn.1671-4040.2021.21.018.
[14] NOORI S,HASSAN Z M,YAGHMAEI B,et al.Antitumor and immunomodulatory effects of salvigenin on tumor bearing mice[J].Cell Immunol,2013,286(1/2):16-21.
[15] Chan SC,Chang YS,Wang JP,Chen SC,Kuo SC. Three new flavonoids and antiallergic , anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med. 1998 Mar ;64(2):153-8.doi:10.1055/s-2006-957394.PMID:9525107.
[16] 唐亚芳,杨岸新.中药川芎的有效成分及其药理作用 研 究 [J]. 中 国 现 代 药 物 应 用 , 2018 ,12(10):219-220.DOI:10.14164/j.cnki.cn11-5581/r.2018.10.125.
[17] 杨丽.当归、鸡血藤、丹参、红花补血与活血之探讨[J].中国中医急症,2010,19(09):1566-1567.
[18] Huang W C ,Liou C J .Dietary Acacetin Reduces Airway Hyperresponsiveness and Eosinophil Infiltration by Modulating Eotaxin-1 and Th2 Cytokines in a Mouse Model of Asthma[J]. Evidence-Based Complementray and Alternative Medicine,2012,(2012-9-24),2012,2012:910520. DOI:10.1155/2012/910520.
[19] Njamen D,Mbafor JT,Fomum ZT,Kamanyi A,Mbanya JC,Recio MC,Giner RM,Má?ez S,Ríos JL. Anti-inflammatory activities of two flavanones,sigmoidin A and sigmoidin B,from Erythrina sigmoidea. Planta Med. 2004 Feb ;70(2):104-7. doi:10.1055/s-2004-815484.PMID: 14994185.
[20] Biyiti L,Pesando D,Puiseux-Dao S,Girard JP,Payan P. Effect of antibacterial plant flavanones on the intracellular calcium compartment involved in the first cleavage of sea urchin eggs. Toxicon. 1990;28(3):275-83. doi:10.1016/0041-0101(90)90063-d. PMID: 2343463.
[21] Huang YX,Li NF,Li CY,Zheng FP,Yao XY,Lin BH,Huang XZ,Zhao NJ,Yang JY,Chen QM,Zhang MM,Yi LT,Chen XQ. Clinical features and effectiveness of Chinese medicine in patients with COVID-19 from overseas: A retrospective study in Xiamen,China. Front Public Health. 2022 Oct 24;10:1038017. doi: 10.3389/fpubh.2022.1038017. PMID: 36353282; PMCID: PMC9638095.
[22] Tsai PJ,Huang WC,Hsieh MC,Sung PJ,Kuo YH,Wu WH. Flavones Isolated from Scutellariae radix Suppress Propionibacterium Acnes-Induced Cytokine Production In Vitro and In Vivo. Molecules. 2015 Dec 24;21(1):E15. doi: 10.3390/molecules 21010015. PMID: 26712724 ; PMCID: PMC 6273464.
[23] Ren Q,Guo F,Tao S,Huang R,Ma L,Fu P. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. Biomed Pharmacother. 2020 Feb;122:109772. doi: 10.1016/j.biopha.2019.109772. Epub 2019 Dec 30. PMID: 31918290.
[24] Sendler M,van den Brandt C,Glaubitz J,Wilden A,Golchert J,Weiss FU,Homuth G,De Freitas Chama LL,Mishra N,Mahajan UM,Bossaller L,V?lker U,Br?ker BM,Mayerle J,Lerch MM. NLRP3 Inflammasome Regulates Development of Systemic Inflammatory Response and Compensatory Anti-Inflammatory Response Syndromes in Mice With Acute Pancreatitis. Gastroenterology. 2020 Jan;158(1):253-269.e14.doi:10.1053/j.gastro.2019.09.040.Epub 2019 Oct 5.PMID:31593700.
[25] 潘静,张兵,党春晓,等.逍遥舒坤汤通过 PI3K/Akt/ mTOR 调控中性粒细胞胞外诱捕网治疗盆腔炎性疾病后遗症的机制[J/OL].中国实验方剂学杂志,1-14
[2024-12-13].https://doi.org/10.13422/j.cnki.syfjx. 20242236.
[26] 刘云,张小兵,张向明,等.丹皮酚对脓毒症小鼠心肌炎的保护作用及机制研究[J].中国临床研究,2024,37(11):1714-1718.DOI:10.13429/j.cnki. cjcr. 2024. 11.014.
[27] 李赋,张志明,张茂福,等.肺泡巨噬细胞自噬在急性肺损伤/急性呼吸窘迫综合征中的研究进展[J].中国急救医学,2024,44(11):1002-1006.
[28] 程蒙蒙,刘新光,魏焱鑫,等.通塞颗粒阻抑巨噬细胞炎症反应改善大鼠慢性阻塞性肺疾病急性加重[J].南方医科大学学报,2024,44(10):1995-2003.
[29] 范晓璇,颜培正,张庆祥.黄芪甲苷通过 LC3/Beclin 1 干预哮喘寒饮蕴肺证大鼠细胞自噬的机制[J].中华中医药杂志,2024,39(11):6037-6042.
[30] 易阳,周国平,钟闻燕,等.中性粒细胞、白介素-8 和弹性蛋白酶在急性毛细支气管炎发病中的作用[J].临床儿科杂志,2009,27(02):148-151.
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.

 
Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
关于 Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Joining the Editorial Board, Associate Editors, Peer Reviewers, and Editor-in-Chief
加入编委、副主编、同行评审专家及主编
Quest Press
Bridging Research to a Global Stage.
academia
© 2025-2026 Macau Sino-Foreign Medical Publishing Ltd.(MSFMP)
Address: Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Tel: +853 6881 9699 / Email: QuestPress@hotmail.com
The MSFMP publishes articles under the following open access license.
Quest Press
is a member of the following organizations.